viewEuromoney Institutional Investor

Euromoney revenues hit by weak asset management division

The strategic review of the ailing asset management division, which is currently being held for sale, is “progressing well” after beginning in September

Euromoney Institutional Investor  -

Euromoney Institutional Investor PLC (LON:ERM) said that it is “progressing well” with a strategic review of its asset management segment, which is continuing to dent revenues.

In its full year results on Thursday, the FTSE 250 financial information specialist said reported total revenue for the year to the end of September increased by 3% to £401.7mln, supported by the acquisitions of executive profiling platform BoardEx and mergers and acquisitions data company The Deal.

READ: Euromoney cashes in as 2019 beats expectations

The group’s pricing business generated almost half of total revenue and saw underlying revenue growth of 4%, which also helped boost adjusted operating profit 5% to £105.4mln.

However, this was dented by “structural and cyclical issues” that continued to batter its asset management segment, which accounts for a third of revenues and declined by 4% in the year ending in September.

Euromoney said that its strategic review of the ailing division, which is currently being held for sale, is “progressing well” after beginning in September.

Andrew Rashbass, chief executive, said that the period saw a “continuation of recent trends in our businesses, with good momentum for our pricing, data and market intelligence products offset by conditions in asset management markets”.

Weakness in the segment is expected to continue into 2020, but the company says that this should be accompanied by good growth in pricing.

Broker Peel Hunt commented on the results, saying that “an imprecise outlook comment lacks relevance given the transformational impact the strategic review of the asset management division may have”.

Analysts added that it should become clear “early next year” what the potential value the market may pay for Euromoney’s asset management division.

The dividend per share also rose 2% to 33.1p for the full year.

Shares were little moved, up 0.3% at 1,316p in Thursday morning trading.

Quick facts: Euromoney Institutional Investor

Price: 815.3434 GBX

Market: LSE
Market Cap: £891.08 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Amryt Pharma releases Q-2 financials that show strong revenue growth as...

Amryt Pharma (Nasdaq: AMYT) CEO Dr Joe Wiley joined Steve Darling from Proactive with news the company saw a nice increase in revenue as they released their Q-2 numbers. Dr Wiley talked about some of the numbers and what was driving that revenue. Wiley also told Proactive the company has, for...

21 minutes ago

2 min read